Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14850, USA.
Lab Chip. 2018 Oct 23;18(21):3285-3292. doi: 10.1039/c8lc00939b.
The global healthcare landscape is experiencing increasing demand for CLIA-waived testing facilities that offer diagnostic capabilities at lower costs and greater convenience than traditional laboratory testing. While several new diagnostic tools have emerged to fulfill testing requirements in these environments, centrifuges have been stymied from transitioning to the point-of-need as the US Food and Drug Administration (FDA) classifies them as mostly unsuitable for use in CLIA-waived environments. Limitations in sample processing capabilities adversely affects the ability for CLIA-waived testing environments to offer a broad testing portfolio and present-day diagnostics are bottlenecked by the requirement for centrifugation. Here we present the High Efficiency Rapid Magnetic Erythrocyte Separator (H.E.R.M.E.S), a rapid low-cost technology that can perform the separation of red blood cells from plasma at a fraction of the time and cost of that of a centrifuge. We demonstrate that H.E.R.M.E.S is able to obtain highly-pure plasma (greater than 99.9% purity) at less than 2 minutes per test. Further, we detail that it is an easy-to-use method capable of being incorporated with present-day diagnostic technologies and prove that it is superior to existing alternatives to centrifugation by validation with a ferritin lateral flow test. H.E.R.M.E.S is a suitable alternative for centrifugation in point-of-need settings and aims to facilitate the decentralization of commercial blood testing.
全球医疗保健领域对 CLIA 豁免检测设施的需求不断增加,这些设施提供的诊断功能成本更低、便利性更高,优于传统的实验室检测。虽然已经出现了一些新的诊断工具来满足这些环境下的检测要求,但由于美国食品和药物管理局 (FDA) 将离心机归类为在 CLIA 豁免环境中大多不适合使用,因此它们在向即时检测环境过渡方面受到了阻碍。在样本处理能力方面存在的局限性,极大地影响了 CLIA 豁免检测环境提供广泛检测组合的能力,而当前的诊断技术则受到需要离心的限制。在这里,我们提出了高效快速磁红细胞分离器 (H.E.R.M.E.S),这是一种快速、低成本的技术,能够在离心机所需时间和成本的一小部分内完成红细胞与血浆的分离。我们证明 H.E.R.M.E.S 能够在不到 2 分钟的时间内获得高度纯净的血浆(纯度大于 99.9%)。此外,我们详细说明了它是一种易于使用的方法,能够与当前的诊断技术相结合,并通过铁蛋白侧向流动测试验证证明其优于现有的离心替代方法。H.E.R.M.E.S 是即时检测环境中离心的理想替代品,旨在促进商业血液检测的分散化。